Attune NXT 4 laser serial#-(2AFC224450219) AB assurance 1PM
Ended Awarded
- Contract number
- 75N91022F00007
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7 Part of Thermo Electron Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,657
Award facts
- Contract value 100% obligated
- $16,657.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $16,657.48 firm fixed price BPA call contract to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on April 8, 2022, with an ultimate completion date of April 28, 2023. The contract, which utilized no set-aside designation, covers the supply of an ATTUNE NXT 4 LASER (Serial #2AFC224450219) with AB Assurance 1PM coverage and is performed in Bethesda, Maryland. Life Technologies Corporation is a major supplier of scientific instruments and laboratory equipment to federal agencies, with particular expertise in biotechnology products including genetic analyzers, real-time PCR systems, flow cytometers, and DNA sequencers that support critical research initiatives across the National Institutes of Health and other federal agencies.
This call order is executed under an existing Blanket Purchase Agreement vehicle, a procurement mechanism that enables the National Cancer Institute to access specialized scientific instrumentation and support services from this established contractor without requiring new solicitations. Thermo Fisher Scientific's parent entity, Thermo Electron Corporation, maintains substantial federal contracting relationships across multiple agencies and maintains several significant IDVs, including agreements with the FDA and Department of Veterans Affairs. The ATTUNE NXT 4 laser system, paired with the comprehensive assurance coverage, provides the National Cancer Institute with advanced flow cytometry capability essential for cancer research and diagnostics.
Quick answers
Who was awarded contract 75N91022F00007?
75N91022F00007 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on April 8, 2022.
How much is contract 75N91022F00007 worth?
The government has obligated $16,657 on 75N91022F00007.
Is contract 75N91022F00007 an order under another contract?
Yes. 75N91022F00007 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract 75N91022F00007 competed?
The extent of competition for 75N91022F00007 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award